Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CNY)
Sales 2016 2 750 M
EBIT 2016 916 M
Net income 2016 783 M
Debt 2016 831 M
Yield 2016 -
Sales 2017 3 391 M
EBIT 2017 1 145 M
Net income 2017 991 M
Debt 2017 66,7 M
Yield 2017 0,10%
P/E ratio 2016 21,88
P/E ratio 2017 16,99
EV / Sales2016 6,56x
EV / Sales2017 5,10x
Capitalization 17 216 M
More Financials
Company
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.The company... 
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Surperformance© ratings of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More Ratings
Latest news on 3SBIO INC. (ADR)
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/17 3SBIO : PEG-irinotecan Wins IND Approval From China FDA
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
03/04 3SBIO : adds stake in CP Guojian Pharma at Rmb3.9bn
02/23 3SBIO : Wins Financing for Further Equity Investment
02/23 3SBIO : inks Rmb2.2bn term loan facility
01/27 3SBIO : to add stake in CP Guojian Pharmaceutical
01/20 3SBIO : to add stake in CP Guojian
01/05DJChinese Drugmaker Plans up to $3 Billion Hong Kong IPO
More news
Sector news : Biopharmaceuticals
07/01DJMERCK : to Buy Brazilian Animal-Health Company
07/01DJMERCK : to Buy Brazilian Animal-Health Company for $400 Million
07/01DJSHIRE : Files 8K - Other Events
07/01DJVALEANT PHARMACEUTICALS INTL : Pershing Square Lays Off Eight Lower-Level Employ..
07/01DJAstraZeneca Ends European Licensing Pact With Valeant
More sector news : Biopharmaceuticals
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions